260 related articles for article (PubMed ID: 32856072)
1. Sentinel lymph node biopsy may be unnecessary for ductal carcinoma in situ of the breast that is small and diagnosed by preoperative biopsy.
Uemoto Y; Kondo N; Wanifuchi-Endo Y; Asano T; Hisada T; Nishikawa S; Katagiri Y; Terada M; Kato A; Okuda K; Sugiura H; Kato H; Takahashi S; Toyama T
Jpn J Clin Oncol; 2020 Dec; 50(12):1364-1369. PubMed ID: 32856072
[TBL] [Abstract][Full Text] [Related]
2. A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
Yoo TK; Kim SJ; Lee J; Lee SB; Lee SJ; Park HY; Park HK; Chae BJ; Eom YH; Kim HS; Song BJ
Clin Breast Cancer; 2020 Jun; 20(3):e281-e289. PubMed ID: 32147404
[TBL] [Abstract][Full Text] [Related]
3. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
Shin YD; Lee HM; Choi YJ
BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
[TBL] [Abstract][Full Text] [Related]
4. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
Watanabe Y; Anan K; Saimura M; Koga K; Fujino M; Mine M; Tamiya S; Nishihara K; Nakano T; Mitsuyama S
Breast Cancer; 2018 Nov; 25(6):663-670. PubMed ID: 29786772
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
[TBL] [Abstract][Full Text] [Related]
6. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
Ramzi S; Najeeb E; Coulthard J; Jenkins S
Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
[TBL] [Abstract][Full Text] [Related]
7. Significance of a positive sentinel lymph node biopsy in staging for distant metastasis in breast cancer: are current guidelines relevant?
Hubbard T; Ives C
Ann R Coll Surg Engl; 2020 Jul; 102(6):429-436. PubMed ID: 32326728
[TBL] [Abstract][Full Text] [Related]
8. Ductal Carcinoma In Situ with Microinvasion on Core Biopsy: Evaluating Tumor Upstaging Rate, Lymph Node Metastasis Rate, and Associated Predictive Variables.
Phantana-Angkool A; Voci AE; Warren YE; Livasy CA; Beasley LM; Robinson MM; Hadzikadic-Gusic L; Sarantou T; Forster MR; Sarma D; White RL
Ann Surg Oncol; 2019 Nov; 26(12):3874-3882. PubMed ID: 31342378
[TBL] [Abstract][Full Text] [Related]
9. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
[TBL] [Abstract][Full Text] [Related]
10. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
[TBL] [Abstract][Full Text] [Related]
11. Sentinel node biopsy in ductal carcinoma in situ of the breast: Never justified?
Sorrentino L; Sartani A; Bossi D; Amadori R; Nebuloni M; Truffi M; Bonzini M; Riggio E; Foschi D; Corsi F
Breast J; 2018 May; 24(3):325-333. PubMed ID: 29024241
[TBL] [Abstract][Full Text] [Related]
12. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
[TBL] [Abstract][Full Text] [Related]
13. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
[TBL] [Abstract][Full Text] [Related]
14. [Sentinel lymph node metastasis in patients with ductal breast carcinoma in situ].
Ruvalcaba-Limón E; de Jesús Garduño-Raya M; Bautista-Piña V; Trejo-Martínez C; Maffuz-Aziz A; Rodríguez-Cuevas S
Cir Cir; 2014; 82(2):129-41. PubMed ID: 25312311
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
van Roozendaal LM; Goorts B; Klinkert M; Keymeulen KBMI; De Vries B; Strobbe LJA; Wauters CAP; van Riet YE; Degreef E; Rutgers EJT; Wesseling J; Smidt ML
Breast Cancer Res Treat; 2016 Apr; 156(3):517-525. PubMed ID: 27083179
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy in patients with pure and high-risk ductal carcinoma in situ of the breast.
D'Eredità G; Giardina C; Napoli A; Ingravallo G; Troilo VL; Fischetti F; Berardi T
Tumori; 2009; 95(6):706-11. PubMed ID: 20210234
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of sentinel and non-sentinel lymph node metastases in patients with ductal carcinoma in situ of the breast: A nationwide study.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Breast; 2018 Dec; 42():128-132. PubMed ID: 30257226
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
[TBL] [Abstract][Full Text] [Related]
19. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
[TBL] [Abstract][Full Text] [Related]
20. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
Maeda H; Hayashida T; Watanuki R; Kikuchi M; Nakashoji A; Yokoe T; Seki T; Takahashi M; Kitagawa Y
Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
